Physician

Carol Ann Trakimas, D.O.

According to 2025 Medicare claims, Carol Trakimas, D.O. (NPI: 1144396342) practices dermatology in the Goldsboro, NC market, with the plurality of this provider's patient population coming from Wayne, NC. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY, S.C. (NPI: 1326532169; TIN: 391351587) and primary practice location at 27534-9424.

Trakimas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 490 traditional Medicare patients, billed 3,359 HCPCS/CPT codes, and received $145,904 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 676 prescription claims across 247 beneficiaries totaling $243,170 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 126 records totaling $2,683. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $62,363 and ending at $145,904. Concurrently, Part D prescription costs have risen steadily, from $33,505 to $243,170. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$102K$204K2015 Medicare payment: $62,363 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $63,294 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $49,795 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $32,052 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $47,143 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $16,317 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $203,661 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $195,059 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $100,732 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $145,904 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153591,674$62,363
20163361,864$63,294
20173121,435$49,795
2018202971$32,052
20192471,179$47,143
2020135587$16,317
20214533,139$203,661
20226504,539$195,059
20234172,539$100,732
20244903,359$145,904

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$176K$351K2015 Drug cost: $33,505 (USD; Tot_Drug_Cst)2016 Drug cost: $15,422 (USD; Tot_Drug_Cst)2017 Drug cost: $20,637 (USD; Tot_Drug_Cst)2018 Drug cost: $17,456 (USD; Tot_Drug_Cst)2019 Drug cost: $23,630 (USD; Tot_Drug_Cst)2020 Drug cost: $16,339 (USD; Tot_Drug_Cst)2021 Drug cost: $90,147 (USD; Tot_Drug_Cst)2022 Drug cost: $345,978 (USD; Tot_Drug_Cst)2023 Drug cost: $351,243 (USD; Tot_Drug_Cst)2024 Drug cost: $243,170 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201585226$33,505
201673152$15,422
201791214$20,637
201890173$17,456
2019117246$23,630
202061128$16,339
2021133255$90,147
2022199485$345,978
2023197450$351,243
2024247676$243,170

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths200256$78
11102Biopsy of related skin growth, first growth136157$58
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more343507$58
17000Destruction of precancer skin growth, 1 growth216281$32
17003Destruction of precancer skin growth, 2-14 growths1721,205$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab20560$82,786
Clobetasol PropionateClobetasol Propionate1343,969$5,071
FluorouracilFluorouracil531,565$3,600
Clindamycin PhosphateClindamycin Phosphate491,449$2,351
DesonideDesonide30798$1,199

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.126$2,683ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carol Ann Trakimas, D.O.?

Tedicare shows public-source Medicare data for Carol Ann Trakimas, D.O. (NPI 1144396342), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carol Ann Trakimas, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carol Ann Trakimas, D.O.?

Carol Ann Trakimas, D.O. is linked to FOREFRONT DERMATOLOGY, S.C. (billing NPI 1326532169) in the available physician profile data.

Does Carol Ann Trakimas, D.O. have Open Payments data?

Carol Ann Trakimas, D.O. has 126 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.